您的购物车当前为空
[Topoisomerasell/ME-1-IN-1 (Compound 7a)] 是一种Topoisomerasell/ME-1双重抑制剂,对Topoisomerasell 的IC50为5.03 μM,并可功能性抑制TopoisomeraseII 和阻断ME-1活性。该化合物可通过上调Beclin-1和LC3-II表达诱导自噬 (Autophagy),同时促进凋亡 (Apoptosis),对乳腺癌细胞表现出抗增殖活性且对正常乳腺上皮细胞无毒性,可用于乳腺癌(包括三阴性乳腺癌)的相关研究。
[Topoisomerasell/ME-1-IN-1 (Compound 7a)] 是一种Topoisomerasell/ME-1双重抑制剂,对Topoisomerasell 的IC50为5.03 μM,并可功能性抑制TopoisomeraseII 和阻断ME-1活性。该化合物可通过上调Beclin-1和LC3-II表达诱导自噬 (Autophagy),同时促进凋亡 (Apoptosis),对乳腺癌细胞表现出抗增殖活性且对正常乳腺上皮细胞无毒性,可用于乳腺癌(包括三阴性乳腺癌)的相关研究。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 10 mg | 待询 | 待询 | |
| 50 mg | 待询 | 待询 |
TargetMol的所有产品仅用作科学研究或药证申报,不能被用于人体,我们不向个人提供产品和服务。请您遵守承诺用途,不得违反法律法规规定用于任何其他用途。
| 产品描述 | Topoisomerasell/ME-1-IN-1 (Compound 7a) is an inhibitor of both Topoisomerasell and ME-1, with an IC50 of 5.03 μM for Topoisomerasell. It effectively suppresses Topoisomerase II activity and functionally blocks ME-1 activity. The compound induces autophagy by upregulating Beclin-1 and LC3-II expression. Additionally, Topoisomerasell/ME-1-IN-1 promotes apoptosis and exhibits antiproliferative effects on breast cancer cells without being toxic to normal breast epithelial cells. This compound is applicable for research related to breast cancer, including triple-negative breast cancer. |
| 靶点活性 | Topoisomerase II:5.03 μM |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. 实际储存温度请以COA为准 |
对于不同动物的给药剂量换算,您也可以参考 更多